Clinical Trials Directory

Trials / Completed

CompletedNCT05304273

Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages

COMPARATIVE STUDY OF EFFECTS BETWEEN LETROZOLE PLUS MISOPROSTOL AND MIFEPRISTONE PLUS MISOPROSTOL IN TERMINATING NON-VIABLE FIRST TRIMESTER PREGNANCIES

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Calcutta National Medical College and Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Prospective interventional study where participants with non-viable pregnancy at 1st trimester will be randomized into two arms, one group will receive conventional treatment with oral mifepristone followed by misoprostol vaginally and another group will receive letrozole for three consecutive days followed by misoprostol vaginally in an attempt to terminate the pregnancy medically. Mean duration of induction to expulsion of product of conception and rate of complete abortion will be compared in two groups.

Conditions

Interventions

TypeNameDescription
DRUGMifepristoneParticipants with 1st trimester miscarriage will receive for medical termination
DRUGLetrozoleParticipants with 1st trimester miscarriage will receive for medical termination

Timeline

Start date
2022-05-05
Primary completion
2024-07-26
Completion
2024-10-01
First posted
2022-03-31
Last updated
2026-04-02

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05304273. Inclusion in this directory is not an endorsement.